text: 3.2. Molecular Mechanisms Mediating the Perinatal Beta-Cell Adaptive Response to Early-Life Stressors
  Molecular mechanisms responsible for impaired beta-cell mass formation after IUCR or IUPR have come under investigation.
  First, it has been proposed that IUCR can result in a reduction of the embryonic beta-cell progenitor pool leading to inappropriate postnatal beta-cell formation. Stanger et al. [108] demonstrated that selective genetic reduction in the size of PDX-1+ pancreatic progenitors during the fetal period results in impaired beta-cell formation during the postnatal period with consequent development of glucose intolerance during adulthood. Consistent with this, maternal food restriction leads to significant reduction in PDX-1+ and neurogenin-3+ pancreatic precursors during embryonic development in rats, diminished postnatal beta-cell formation, and inability to expand beta-cell mass in response to pregnancy [47, 94]. The UPI model is also characterized by a permanent decrease in islet PDX-1 mRNA expression. This decrease has recently been shown to be due to progressive epigenetic silencing of the Pdx1 gene locus secondary to proximal promoter methylation [69, 109], and it may be responsible for the decreased rate of beta-cell replication and inappropriate postnatal beta-cell mass development [69, 110]. In the same way of thinking, studies have demonstrated that the maintenance of methylated histone H3 Lys4 by Set7/9, a member of the SET methyltransferase family, is crucial to Pdx1 activity in beta-cell lines [111-113]. This led to the hypothesis that Set7/9 may represent a novel chromatin-modifying protein that functions in part through its recruitment to target genes by cell-specific transcription factors such as Pdx1. Since then, a role of histone methyl transferases, particularly set7, has also been demonstrated in the sustained deleterious effects of chronic hyperglycemia on human microvascular endothelial cells [114]. Such an epigenetic change could potentially be involved in the deleterious effect of high glucose upon the fetal pancreas in the IUED models.
  Another mechanism proposed to explain reduced beta-cell formation after IUCR is related to prenatal glucocorticoid exposure. Administration of either dexamethasone or carbenoxolone (to inhibit 11 beta-hydroxysteroid dehydrogenase type 2) to normal pregnant rats also causes fetal growth retardation and the adult offspring are hypertensive and hyperglycemic, with hyperactive hypothalamic-pituitary-adrenal axis [115]. Maternal undernutrition significantly increased both fetal and maternal corticosterone concentrations in rats [116]. Subsequently, maternal and/or fetal overexposure to glucocorticoids (via administration of dexamethasone) impairs both fetal and postnatal beta-cell formation in rodents and nonhuman primates [94, 117-119]. Seckl et al. [115] have shown that fetal corticosterone concentrations are inversely correlated with fetal insulin content and postnatal beta-cell formation in rats. Evidence suggests that glucocorticoids can exert a direct effect on the developing fetal pancreas via transcriptional modulation of transcription factors involved in beta-cell formation and differentiation [117]. Glucocorticoid receptors are present in the pancreas during embryonic development of rodents and humans [117], and glucocorticoids can bind to the Pdx1 promoter and thus suppress fetal endocrine cell differentiation [117]. Glucocorticoid treatment has been shown to significantly reduce fetal expression of key endocrine transcription factors such as Pdx1 and Pax6 but simultaneously increase expression of transcription factors that regulate development of the exocrine pancreas [119].
  It has also been demonstrated that the UPI or the low-protein IUPR offspring experience increased oxidative stress and impaired mitochondrial function [96, 120]. The mitochondrial dysfunction was not limited to just the beta cell, as mitochondria from both the liver and skeletal muscle exhibit decreased oxidation of pyruvate, subsequently leading to the development of features commonly found in T2D [100, 121]. Also exposure to a Western-style diet before and during pregnancy (an IUEO model) alters the redox state as early as preimplantation development, leading to mild oxidative stress associated with inflammation. The finding that administration of antioxidants to the dam reverses oxidative stress and completely prevents the development of glucose intolerance and increased adiposity in the adult offspring suggests that oxidative stress plays an important role in the development of adiposity in this case [122]. Some studies in the low-protein IUPR model have demonstrated that oxidative stress is not limited to just mitochondrial DNA damage, but also to genomic DNA, impacting cell-cycle regulation and gene expression [123]. While DNA is being targeted throughout by ROS, there are particular regions that are known to be more sensitive to ROS-mediated damage, for example, telomeres. Telomeres comprise GC-rich repeats and are found at the ends of each chromosome. They are known to shorten with each cellular division and, hence, can act as a mitotic clock, registering the number of replicative divisions to have taken place within the cell. Investigations using an IUPR model have indeed reported a decrease in longevity in the offspring [123, 124] accompanied by reduction in mitochondrial antioxidant defences [96, 125] and telomere length in islets [125].
  Pancreatic islet development has been shown to be influenced by a number of growth factors including the insulin-like growth factors, IGF-I and IGF-II whose expression in utero is regulated by nutrient and hormone concentrations. IUPR modifies expression of both IGF genes in a variety of fetal tissues. In an IUPR rat model with a decreased beta-cell mass and beta-cell replication and an increased rate of beta-cell apoptosis, gene expression for IGF-II but not IGF-I was found reduced in the fetal pancreas [126]. In a different IUPR model with more severe global food restriction which induced hyperinsulinemia and an increase in beta-cell mass in their fetuses [90], the fetal phenotype was unexpectedly associated with an increase in pancreatic IGF-I expression, islet IGF-1R [91], and IRS-2 [92]. In the fetal GK/Par rat exposed to mild hyperglycemia during gestation (a model of IUED), data from our group suggest that the beta-cell deficit (reduced by more than 50%) starts as early as fetal age E16 and reflects decreased beta-cell proliferation, a limitation of beta-cell neogenesis from precursors, and increased apoptosis of both beta cells and their precursors [86]. Notably, Pdx1 and Neurogenin3 expression were decreased on E18 but normally expressed on E13 [86]. Defective signalling through the Igf2/Igf1-R pathway may represent the primary instrumental anomaly since Igf2 and Igf1-R protein expressions are already decreased within the GK/Par pancreatic rudiment at E13, at a time when beta-cell mass (first wave of beta-cell expansion) is in fact normal [31]. Low levels of pancreatic Igf2 associated with beta-cell mass deficiency are maintained thereafter within the fetal pancreas [87]. Crossbreeding protocols between nondiabetic W and diabetic GK rats showed that, in late gestation (E18), pancreatic Igf2 protein expression was as low in GKmother/GKfather and Wmother/GKfather crosses as in GKmother/GKfather crosses [87]. These findings rather support the hypothesis that the pancreatic Igf2 anomaly in the GK diabetic model is linked to a genetic determinism. This view is also consistent with the results of genetic analyses that linked a locus containing the gene encoding Igf2 to diabetes in the GK rat [127]. The Igf2 gene is subjected to paternal genomic imprinting. However, because the Igf2 expression is similarly affected in fetuses, regardless of whether the father is W or GK [87], we cannot conclude with a simple change of Igf2 gene imprinting in the GK rat.
  Finally, our understanding of the underlying mechanisms for reduced BCM in response to inappropriate perinatal nutrition is growing rapidly. However, the relative contribution of the many intrinsic and extrinsic factors which contribute to the adaptive response of the developing endocrine pancreas is still to be established.
  
entities.text: ['Beta-Cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T1
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T2
entities.text: ['embryonic beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T3
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T4
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T5
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T6
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T7
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T8
entities.text: ['embryonic']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T9
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T10
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T11
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T12
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T13
entities.text: ['beta-cell lines']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T14
entities.text: ['cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T15
entities.text: ['microvascular endothelial cells']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T16
entities.text: ['fetal pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T17
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T18
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T19
entities.text: ['hypothalamic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T20
entities.text: ['pituitary']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T21
entities.text: ['adrenal']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T22
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T23
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T24
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T25
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T26
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T27
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T28
entities.text: ['fetal pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T29
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T30
entities.text: ['pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T31
entities.text: ['embryonic']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T32
entities.text: ['fetal endocrine cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T33
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T34
entities.text: ['exocrine pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T35
entities.text: ['beta cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T36
entities.text: ['mitochondria']
entities.type: Cellular_component
entities.entity_id: PMC-3202114-sec-05_T37
entities.text: ['liver']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T38
entities.text: ['skeletal muscle']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T39
entities.text: ['cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T40
entities.text: ['cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T41
entities.text: ['islets']
entities.type: Multi-tissue_structure
entities.entity_id: PMC-3202114-sec-05_T42
entities.text: ['Pancreatic islet']
entities.type: Multi-tissue_structure
entities.entity_id: PMC-3202114-sec-05_T43
entities.text: ['fetal tissues']
entities.type: Tissue
entities.entity_id: PMC-3202114-sec-05_T44
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T45
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T46
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T47
entities.text: ['fetal pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T48
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T49
entities.text: ['fetuses']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T50
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T51
entities.text: ['islet']
entities.type: Multi-tissue_structure
entities.entity_id: PMC-3202114-sec-05_T52
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T53
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T54
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T55
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T56
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T57
entities.text: ['beta cells']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T58
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T59
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T60
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T61
entities.text: ['beta-cell']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T62
entities.text: ['fetal pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T63
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T64
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T65
entities.text: ['fetuses']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T66
entities.text: ['endocrine pancreas']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T67
entities.text: ['cellular']
entities.type: Cell
entities.entity_id: PMC-3202114-sec-05_T68
entities.text: ['fetal']
entities.type: Developing_anatomical_structure
entities.entity_id: PMC-3202114-sec-05_T69
entities.text: ['pancreatic']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T70
entities.text: ['pancreatic rudiment']
entities.type: Organ
entities.entity_id: PMC-3202114-sec-05_T71
entities.text: ['mitochondrial']
entities.type: Cellular_component
entities.entity_id: PMC-3202114-sec-05_T72
entities.text: ['mitochondrial']
entities.type: Cellular_component
entities.entity_id: PMC-3202114-sec-05_T73
entities.text: ['mitochondrial']
entities.type: Cellular_component
entities.entity_id: PMC-3202114-sec-05_T74
entities.text: ['mitochondrial']
entities.type: Cellular_component
entities.entity_id: PMC-3202114-sec-05_T75
entities.text: ['islet']
entities.type: Multi-tissue_structure
entities.entity_id: PMC-3202114-sec-05_T76